Detailed Quote
5i Report
Rating
A-
Review of Shopify Inc.
MAY 09, 2024 - Shopify (SHOP) is a leading global commerce company that provides essential internet infrastructure for commerce, offering tools to start, scale, market, and run a business. SHOP’s business model embodies scalability and alignment with customers (merchants). The business has continually added to its solution offering and now essentially offers a solution for every business – no matter the size. SHOP continues to be one of our favourite growth names and we are maintaining our rating of an A-.
Download ReportCompany Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
- NVIDIA Corporation (NVDA)
- Shopify Inc. Class A Subordinate Voting Shares (SHOP)
- Vertiv Holdings LLC Class A (VRT)
Q: Names like VRT, NVDA, SHOP have now corrected about 15%. I like to buy in these situations all the while being fully aware that I suck at timing the bottom of a correction, knowing only that I am getting a deal compared to recent highs. My questions are: Any red flags on any of these? Do you see other names with similar or greater pullbacks that are equally or more compelling? A list of those would be appreciated. Thank-you.
- TFI International Inc. (TFII)
- Magna International Inc. (MG)
- Shopify Inc. Class A Subordinate Voting Shares (SHOP)
- goeasy Ltd. (GSY)
- Boyd Group Services Inc. (BYD)
Q: As Trump’s inauguration approaches and our government falters it appears increasingly likely that the risk of tariffs is not zero. Yet Canadian markets don’t seem concerned. Do you have any guidance current Canadian equity holdings? The answer to these problems is usually to do nothing but it looks as though there is potential for serious market disruption.
Within your portfolio recommendations (my largest would be Tfii, gsy, shop, mg, byd ) do you see companies that are high risk of significant harm?
Within your portfolio recommendations (my largest would be Tfii, gsy, shop, mg, byd ) do you see companies that are high risk of significant harm?
Q: I see 3 new analyst ratings this week. One buy and two holds. Small sample but not a ringing endorsement. Has anything changed? It had a particularly rough day yesterday. Does it still make your top 5 growth stock picks or has it fallen down the list? What do you see going forward>
Insiders
Share Information
News and Media